DSC MRI Biomarker Ctte: Difference between revisions
Jump to navigation
Jump to search
| Line 17: | Line 17: | ||
*[[Media:2020_06-10_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|June 10, 2020]] | *[[Media:2020_06-10_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|June 10, 2020]] | ||
*[[Media:2020_05-13_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|May 13, 2020]] | *[[Media:2020_05-13_QIBA_DSC-MRI_BC_Call_Summary-FINAL.pdf|May 13, 2020]] | ||
<br/> | |||
'''''[[DSC-MRI Call Summaries Archive]]''''' | '''''[[DSC-MRI Call Summaries Archive]]''''' | ||
Revision as of 23:38, 29 September 2020
- Co-chairs: Bradley Erickson, MD, PhD; Ona Wu, PhD
- RSNA Staff Support: Susan Stanfa
Project Snapshot
Develop a quantitative imaging profile for Dynamic Susceptibility Contrast MRI.
DSC MRI Meetings
Recent Approved call summaries:
Note: The last meeting of this group was held on September 9, 2020; notes are posted after they are approved by the DSC-MRI BC during the following t-con
DSC-MRI Call Summaries Archive
- Earlier materials can be found on the PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee page
Profile Development
- DSC Profile Stage 1 Version for Public Comment (comments closed on May 15, 2020)
- DSC Profile Stage 2 Consensus Profile - to be released soon
Historical Background - Formation of the Group
Reference Materials
QIBA Funded Projects
Round 5
- Original Proposal to the QIBA Steering Committee